Rubius Therapeutics, Inc. (16) | License Agreements (1)

Recent Contracts

Second Amendment to the Exclusive Patent License Agreement between the Registrant and the Whitehead Institute for Biomedical Research, dated July 25, 2018 (Filed With SEC on March 28, 2019)